| 臺大學術典藏 |
2020 |
Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry
|
Chiu S.-N.;Weng K.-P.;Lin M.-C.;Wang J.-N.;Hwang B.-T.;Dai Z.-K.;Lin S.-M.;Chang J.-S.;Lin I.-C.;Mei-Hwan Wu;Lu C.-W.;Lin M.-T.;Chen C.-A.;Hua Y.-C.;Wu J.-M.;Wang J.-K.;Tachyon Investigators; Chiu S.-N.; TACHYON investigators; Wang J.-K.; Wu J.-M.; Weng K.-P.; Lin M.-C.; Wang J.-N.; Hwang B.-T.; Dai Z.-K.; Lin S.-M.; Chang J.-S.; Lin I.-C.; MEI-HWAN WU; Lu C.-W.; Lin M.-T.; Chen C.-A.; Hua Y.-C. |
| 臺大學術典藏 |
2020 |
Exercise Capacity and Ventricular Remodeling after Transcatheter Ventricular Septal Defect Closure in Asymptomatic or Minimally Symptomatic Adolescents and Adults
|
Lin M.-T.; Wang J.-K.; Chen C.-A.; Chen C.-A.;Wang J.-K.;Lin M.-T.;Chiu H.-H.;Hsu J.-Y.;Lin S.-M.;Chang Y.-M.;Chiu S.-N.;Lu C.-W.;Mei-Hwan Wu;Yang M.-C.; Chiu H.-H.; Hsu J.-Y.; Lin S.-M.; Chang Y.-M.; Chiu S.-N.; Lu C.-W.; MEI-HWAN WU; Yang M.-C. |
| 臺大學術典藏 |
2020 |
Increased prevalence of inattention-related symptoms in a large cohort of patients with congenital heart disease
|
Wu M.-H.; Chang H.-Y.; Chang L.-Y.; Weng W.-C.; Wang C.-C.; Wang J.-K.; Lu C.-W.; Lin M.-T.; CHUN-AN CHEN; Chiu S.-N. |
| 臺大學術典藏 |
2020 |
Device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants
|
Wang H.-H.; Chien Y.-H.; Lin M.-T.; Lin H.-C.; Lu C.-W.; Chiu S.-N.; Wu M.-H.; Wang J.-K.; CHUN-AN CHEN |
| 國立成功大學 |
2020 |
Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry
|
Chiu, S.-N.;Weng, K.-P.;Lin, M.-C.;Wang, J.-N.;Hwang, B.-T.;Dai, Z.-K.;Lin, S.-M.;Chang, J.-S.;Lin, I.-C.;Wu, M.-H.;Lu, C.-W.;Lin, M.-T.;Chen, Chen C.-A.;Hua, Y.-C.;Wu, J.-M.;Wang, J.-K.;investigators, TACHYON |
| 國立成功大學 |
2020 |
Hybrid White-Light-Emitting Electrochemical Cells Based on a Blue Cationic Iridium(III) Complex and Red Quantum Dots
|
Tang, Y.-H.;Chiu, Y.-C.;Luo, D.;Lien, J.-Y.;Yi, R.-H.;Lin, C.-H.;Yang, Z.-P.;Lu, C.-W.;Su, H.-C. |
| 國立成功大學 |
2020 |
Treatment of epidermal growth factor receptor inhibitor-induced severe paronychia with pyogenic granuloma-like lesions with topical betaxolol: an open-label observation study
|
Yen, C.-F.;Hsu, C.-K.;Yang, H.-S.;Lee, C.-N.;Chi, Chi C.-C.;Chung, W.-H.;Wang, C.-L.;Pang, J.-H.S.;Wang, C.-W.;Ko, Y.-S.;Lu, C.-W. |
| 臺大學術典藏 |
2019-12-19T07:08:31Z |
Dnmt3l-knockout donor cells improve somatic cell nuclear transfer reprogramming efficiency
|
Liao H.-F.; Mo C.-F.; Wu S.-C.; Cheng D.-H.; Yu C.-Y.; Chang K.-W.; Kao T.-H.; Lu C.-W.; Pinskaya M.; Morillon A.; Lin S.-S.; Cheng W.T.K.; Bourc'his D.; Bestor T.; Sung L.-Y.; Lin S.-P.; SHINN-CHIH WU |
| 臺大學術典藏 |
2019-12-04T08:43:33Z |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
|
Chen C.-B.;Hsiao Y.-H.;Wu T.;Hsih M.-S.;Tassaneeyakul W.;Jorns T.P.;Sukasem C.;Hsu C.-N.;Su S.-C.;Chang W.-C.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Sun P.-L.;Lee H.-E.;Yang C.-Y.;Kao P.-H.;Yang C.-H.;Ho H.-C.;Lin J.-Y.;Chang Y.-C.;Chen M.-J.;Lu C.-W.;Ng C.Y.;Kuo K.-L.;Lin C.-Y.;Yang C.-S.;Chen D.-P.;Chang P.-Y.;Wu T.-L.;Lin Y.-J.;Weng Y.-C.;Kuo T.-T.;Hung S.-I.;Chung W.-H.;For The Taiwan Severe Cutaneous Adverse Reaction Consortium; Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium |
| 臺大學術典藏 |
2019-12-04T08:43:28Z |
The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label
|
Yang C.-Y.; Lin Y.-T.; Chi M.-H.; Ho H.-C.; Lin J.-Y.; Yang C.-H.; Chang Y.-C.; Su S.-C.; Wang C.W.; Fan W.-L.; Hung S.-I.; Chung W.-H.; for the Asian Severe Cutaneous Adverse Reaction Consortium; Huang Y.-H.; Lu C.-W.; Chiu T.-M.; Hsu C.-K.; Wu C.-Y.; Chen Y.-J.; CHIA-YU CHU; Hui R.C.-Y.; Cheng B.; Ji C.; Huang J.-W.; Cheung C.M.-T.; Wang Y.-H.;Chen C.-B.;Tassaneeyakul W.;Saito Y.;Aihara M.;Choon S.E.;Lee H.Y.;Chang M.M.;Roa F.D.;Wu C.-W.;Zhang J.;Nakkam N.;Konyoung P.;Okamoto-Uchida Y.;Cheung C.M.-T.;Huang J.-W.;Ji C.;Cheng B.;Hui R.C.-Y.;Chia-Yu Chu;Chen Y.-J.;Wu C.-Y.;Hsu C.-K.;Chiu T.-M.;Huang Y.-H.;Lu C.-W.;Yang C.-Y.;Lin Y.-T.;Chi M.-H.;Ho H.-C.;Lin J.-Y.;Yang C.-H.;Chang Y.-C.;Su S.-C.;Wang C.W.;Fan W.-L.;Hung S.-I.;Chung W.-H.;For The Asian Severe Cutaneous Adverse Reaction Consortium; Wang Y.-H.; Chen C.-B.; Tassaneeyakul W.; Saito Y.; Aihara M.; Choon S.E.; Lee H.Y.; Chang M.M.; Roa F.D.; Wu C.-W.; Zhang J.; Nakkam N.; Konyoung P.; Okamoto-Uchida Y. |
